Next 10 |
A look at the top 10 most actives in the United States Fisker Inc. Class A (FSR) rose 0.1% to $0.1331 on volume of 235,074,479 shares Jaguar Health Inc. (JAGX) rose 16.0% to $0.0799 on volume of 189,600,392 shares BYND Cannasoft Enterprises Inc. (BCAN) rose 2.5% to $0.0205 on volume of 17...
BrainStorm Cell Therapeutics to Unveil Phase 3b NurOwn® Trial Design at MDA Clinical and Scientific Conference PR Newswire Planned Phase 3b trial Designed to Confirm Efficacy and Safety of NurOwn in mild-to-moderate ALS patients NEW YORK , Feb. 2...
2024-02-23 13:24:46 ET More on BrainStorm Cell Therapeutics BrainStorm Cell Therapeutics spikes on patent wins Seeking Alpha’s Quant Rating on BrainStorm Cell Therapeutics Historical earnings data for BrainStorm Cell Therapeutics Financial information ...
BrainStorm Cell Therapeutics Submits Special Protocol Assessment (SPA) Request to FDA for Phase 3b Trial of NurOwn® in ALS PR Newswire NEW YORK , Feb. 23, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult ste...
BrainStorm Cell Therapeutics to Present at European Life Sciences CEO Forum PR Newswire NEW YORK , Feb. 13, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative disea...
NEW YORK, NY / ACCESSWIRE / February 7, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Brainstorm Cell Therapeutics Inc. ("Brainstorm Cell" or "the Company") (NASDAQ:BCLI). Investors who purchased Brainstorm Cell securities prior to Aug...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Brainstorm To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $25,000 investing in Brainstorm securities between August 15, 2022 and September 27, 2023 ...
2023-12-26 10:14:39 ET DENVER, Colo., Dec. 26, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Inspira Technologies Oxy BHN Ltd (NASDAQ: IINN), Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI), 60 Degrees ...
2023-12-26 09:12:31 ET DENVER, Colo., Dec 26, 2023 ( www.247marketnews.com )- Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) provided an update, this morning, on the grant and allowance of three patent applications for NurOwn and NurOwn-Exosomes, by the European Patent office, includi...
2023-12-26 08:19:44 ET More on BrainStorm Cell Therapeutics BrainStorm Cell Therapeutics Inc. (BCLI) Q3 2023 Earnings Call Transcript BrainStorm, FDA to discuss regulatory path forward for ALS therapy Brainstorm realigns resources to support NurOwn development ...
News, Short Squeeze, Breakout and More Instantly...
Brainstorm Cell Therapeutics Inc. Company Name:
BCLI Stock Symbol:
NASDAQ Market:
Brainstorm Cell Therapeutics Inc. Website:
Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news. AbbVie Inc. (NYSE: ABBV) an...
A look at the top 10 most actives in the United States Fisker Inc. Class A (FSR) rose 0.1% to $0.1331 on volume of 235,074,479 shares Jaguar Health Inc. (JAGX) rose 16.0% to $0.0799 on volume of 189,600,392 shares BYND Cannasoft Enterprises Inc. (BCAN) rose 2.5% to $0.0205 on volume of 17...
BrainStorm Cell Therapeutics to Unveil Phase 3b NurOwn® Trial Design at MDA Clinical and Scientific Conference PR Newswire Planned Phase 3b trial Designed to Confirm Efficacy and Safety of NurOwn in mild-to-moderate ALS patients NEW YORK , Feb. 2...